These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24957833)

  • 21. High activity of Fosfomycin and Rifampin against methicillin-resistant staphylococcus aureus biofilm in vitro and in an experimental foreign-body infection model.
    Mihailescu R; Furustrand Tafin U; Corvec S; Oliva A; Betrisey B; Borens O; Trampuz A
    Antimicrob Agents Chemother; 2014 May; 58(5):2547-53. PubMed ID: 24550327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of high-dose daptomycin for therapy of experimental Staphylococcus aureus foreign body infection.
    Schaad HJ; Bento M; Lew DP; Vaudaux P
    BMC Infect Dis; 2006 Apr; 6():74. PubMed ID: 16608512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of a novel rifamycin derivative, ABI-0043, against Staphylococcus aureus in an experimental model of foreign-body infection.
    Trampuz A; Murphy CK; Rothstein DM; Widmer AF; Landmann R; Zimmerli W
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2540-5. PubMed ID: 17502404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of linezolid alone and in combination with rifampin in staphylococcal experimental foreign-body infection.
    Murillo O; Domenech A; Euba G; Verdaguer R; Tubau F; Cabo J; Cabellos C; Gudiol F; Ariza J
    J Infect; 2008 Sep; 57(3):229-35. PubMed ID: 18715649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination therapy with daptomycin, vancomycin, and rifampin for recurrent, severe bone and prosthetic joint infections involving methicillin-resistant Staphylococcus aureus.
    Antony SJ
    Scand J Infect Dis; 2006; 38(4):293-5. PubMed ID: 16718933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial.
    Tong SY; Nelson J; Paterson DL; Fowler VG; Howden BP; Cheng AC; Chatfield M; Lipman J; Van Hal S; O'Sullivan M; Robinson JO; Yahav D; Lye D; Davis JS;
    Trials; 2016 Mar; 17():170. PubMed ID: 27029920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin.
    Sakoulas G; Rose W; Rybak MJ; Pillai S; Alder J; Moellering RC; Eliopoulos GM
    J Clin Microbiol; 2008 Jan; 46(1):220-4. PubMed ID: 18003803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative efficacy of daptomycin and vancomycin in the therapy of experimental foreign body infection due to Staphylococcus aureus.
    Vaudaux P; Francois P; Bisognano C; Li D; Lew DP; Schrenzel J
    J Antimicrob Chemother; 2003 Jul; 52(1):89-95. PubMed ID: 12775678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus in experimental foreign-body infection.
    Baldoni D; Haschke M; Rajacic Z; Zimmerli W; Trampuz A
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1142-8. PubMed ID: 19075065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moxifloxacin plus rifampin as an alternative for levofloxacin plus rifampin in the treatment of a prosthetic joint infection with Staphylococcus aureus.
    Wouthuyzen-Bakker M; Tornero E; Morata L; Nannan Panday PV; Jutte PC; Bori G; Kampinga GA; Soriano A
    Int J Antimicrob Agents; 2018 Jan; 51(1):38-42. PubMed ID: 28668678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship of in vitro synergy and treatment outcome with daptomycin plus rifampin in patients with invasive methicillin-resistant Staphylococcus aureus infections.
    Rose WE; Berti AD; Hatch JB; Maki DG
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3450-2. PubMed ID: 23650174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral-Only Linezolid-Rifampin Is Highly Effective Compared with Other Antibiotics for Periprosthetic Joint Infection: Study of a Mouse Model.
    Thompson JM; Saini V; Ashbaugh AG; Miller RJ; Ordonez AA; Ortines RV; Wang Y; Sterling RS; Jain SK; Miller LS
    J Bone Joint Surg Am; 2017 Apr; 99(8):656-665. PubMed ID: 28419033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations.
    Chuard C; Herrmann M; Vaudaux P; Waldvogel FA; Lew DP
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2611-6. PubMed ID: 1810196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Daptomycin is effective in treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
    Marco F; de la Mària CG; Armero Y; Amat E; Soy D; Moreno A; del Río A; Almela M; Mestres CA; Gatell JM; Jiménez de Anta MT; Miró JM;
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2538-43. PubMed ID: 18426900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention.
    Lora-Tamayo J; Murillo O; Iribarren JA; Soriano A; Sánchez-Somolinos M; Baraia-Etxaburu JM; Rico A; Palomino J; Rodríguez-Pardo D; Horcajada JP; Benito N; Bahamonde A; Granados A; del Toro MD; Cobo J; Riera M; Ramos A; Jover-Sáenz A; Ariza J;
    Clin Infect Dis; 2013 Jan; 56(2):182-94. PubMed ID: 22942204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic Activity of Exebacase (CF-301) in Addition to Daptomycin against Staphylococcus aureus in a Neutropenic Murine Thigh Infection Model.
    Asempa TE; Abdelraouf K; Carabeo T; Schuch R; Nicolau DP
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31818816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacodynamic profile of daptomycin against Enterococcus species and methicillin-resistant Staphylococcus aureus in a murine thigh infection model.
    Dandekar PK; Tessier PR; Williams P; Nightingale CH; Nicolau DP
    J Antimicrob Chemother; 2003 Sep; 52(3):405-11. PubMed ID: 12917254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjunctive Daptomycin in the Treatment of Methicillin-susceptible Staphylococcus aureus Bacteremia: A Randomized, Controlled Trial.
    Cheng MP; Lawandi A; Butler-Laporte G; De l'Étoile-Morel S; Paquette K; Lee TC
    Clin Infect Dis; 2021 May; 72(9):e196-e203. PubMed ID: 32667982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo efficacy of moxifloxacin compared with cloxacillin and vancomycin in a Staphylococcus aureus rabbit arthritis experimental model.
    Grossi O; Caillon J; Arvieux C; Jacqueline C; Bugnon D; Potel G; Hamel A
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3401-3. PubMed ID: 17576849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Staphylococcus aureus resistant to cloxacillin: treatment with fosfomycin-rifampicin].
    Wolff M; Nercelles P; Pepay K
    Rev Med Chil; 1984 Jul; 112(7):665-71. PubMed ID: 6569621
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.